Relapsed/Refractory Mantle Cell Lymphoma
Also known as: Relapsed / Refractory Mantle Cell Lymphoma (MCL)
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB09054 | Idelalisib | 1 | Completed | 1 |
| DB00480 | Lenalidomide | 1 | Completed | 1 |
| DB13915 | Axicabtagene ciloleucel | 2 | Completed | 1 |
| DB15699 | Brexucabtagene autoleucel | 2 | Active Not Recruiting | 1 |
| DB15699 | Brexucabtagene autoleucel | 2 | Completed | 1 |
| DB15699 | Brexucabtagene autoleucel | 2 | Recruiting | 1 |
| DB00531 | Cyclophosphamide | 2 | Active Not Recruiting | 1 |
| DB00531 | Cyclophosphamide | 2 | Completed | 1 |
| DB00531 | Cyclophosphamide | 2 | Recruiting | 1 |
| DB01073 | Fludarabine | 2 | Active Not Recruiting | 1 |
| DB01073 | Fludarabine | 2 | Completed | 1 |
| DB01073 | Fludarabine | 2 | Recruiting | 1 |
| DB09053 | Ibrutinib | 2 | Completed | 1 |
| DB00480 | Lenalidomide | 2 | Completed | 1 |
| DB00073 | Rituximab | 2 | Completed | 1 |